Objective. Fos protein expression in catecholamine-synthesizing neurons of the substantia nigra (SN) pars compacta (SNC, A8), pars reticulata (SNR, A9), and pars lateralis (SNL), the ventral tegmental area (VTA, A10), the locus coeruleus (LC, A6) and subcoeruleus (sLC), the ventrolateral pons (PON-A5), the nucleus of the solitary tract (NTS-A2), the area postrema (AP), and the ventrolateral medulla (VLM-A1) was quantitatively evaluated aft er a single administration of asenapine (ASE) (designated for schizophrenia treatment) in male Wistar rats preconditioned with a chronic unpredictable variable mild stress (CMS) for 21 days. Th e aim of the present study was to reveal whether a single ASE treatment may 1) activate Fos expression in the brain areas selected; 2) activate tyrosine hydroxylase (TH)-synthesizing cells displaying Fos presence; and 3) be modulated by CMS preconditioning.
Methods. Control (CON), ASE, CMS, and CMS+ASE groups were used. CMS included restraint, social isolation, crowding, swimming, and cold. Th e ASE and CMS+ASE groups received a single dose of ASE (0.3 mg/kg, s.c.) and CON and CMS saline (300 μl/rat, s.c.). The animals were sacrificed 90 min aft er the treatments. Fos protein and TH-labeled immunoreactive perikarya were analyzed on double labeled histological sections and enumerated on captured pictures using combined light and fluorescence microscope illumination.
Results. Saline or CMS alone did not promote Fos expression in any of the structures investigated. ASE alone or in combination with CMS elicited Fos expression in two parts of the SN (SNC, SNR) and the VTA. Aside from some cells in the central gray tegmental nuclei adjacent to LC, where a small number of Fos profiles occurred, none or negligible Fos occurrence was detected in the other structures investigated including the LC and sLC, PON-A5, NTS-A2, AP, and VLM-A1. CMS preconditioning did not infl uence the level of Fos induction in the SN and VTA elicited by ASE administration. Similarly, the ratio between the amount of free Fos and Fos colocalized with TH was not aff ected by stress preconditioning in the SNC, SNR, and the VTA.
Conclusions. Th e present study provides an anatomical/functional knowledge about the nature of the acute ASE treatment on the catecholamine-synthesizing neurons activity in certain brain structures and their missing interplay with the CMS preconditioning.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Asmus SE Newman SW. Colocalization of tyrosine hydroxylase and Fos in the male Syrian hamster brain following diff erent states of arousal. J Neurobiol 25 156-168 1994.
Berridge CW Waterhouse BD. Th e locus coeruleus-noradrenergic system: modulation of behavioral state and statedependent cognitive processes. Brain Res Rev 42 33-84 2003.
Bjorklund A Nobin A. Fluorescence histochemical and microspectrofl uorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon. Brain Res 51 193-205 1973.
Blessing WW Hedger SC Joh TH Willoughby JO. Neurons in the area postrema are the only catecholamine-synthesizing cells in the medulla or pons with projections to the rostral ventrolateral medulla (C1-area) in the rabbit. Brain Res 419 336-340 1987.
Bontempi B Sharp FR. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by m opioid receptors in the substantia nigra and ventral tegmental area. J Neurosci 17 8596-8612 1997.
Burns RS Chiueh CC Markey SP Ebert MH Jacobowitz DM Kopin IJ. Primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1236-tetrahydropyridine. Proc Natl Acad Sci USA 80 4546-4550 1983.
Ceccatelli S Villar MJ Goldstein M Hokfelt T. Expression of c-Fos immunoreactivity in transmitter-characterized neurons aft er stress (corticotropin-releasing factor/catecholamine neurons/paraventricular nucleus/medulla oblongata/colchicine). Proc Natl Acad Sci USA 86 9569-9573 1989.
Chan JYH Tsou MY Len WB Lee TY Chan SHH. Participation of noradrenergic neurotransmission in the enhancement of baroreceptor refl ex response by substance P at the nucleus tractus solitarii of the rat: A reverse microdialysis study. J Neurochem 64 2644-2652 1995.
Dahlstrom A Fuxe K. Existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl 4 232 1-55 1964.
Dawe GS Huff KD Vandergriff JL Sharp T O’Neill MJ Rasmussen K. Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 50 510-520 2001.
Deutch AY Tam SY Roth RH. Footshock and conditioned stress increase 34-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res 333 143-146 1985.
Deutch AY Lee MC Gillham MH Cameron DA Goldstein M Iadarola MJ. Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex 1 273-292 1991.
Dragunow M Faull R. Th e use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29 261-265 1989.
Greenberg GD Steinman MQ Doig IE Hao R Trainor BC. Eff ects of social defeat on dopamine neurons in the ventral tegmental area in male and female California mice. Eur J Neurosci 42 3081-3094 2015.
Groger A Kolb R Schafer R Klose U. Dopamine reduction in the substantia nigra of Parkinson’s disease patients confi rmed by in vivo magnetic resonance spectroscopic imaging. PLoS ONE 9 e84081 2014.
Guyenet PG Koshiya N Huangfu D Verberne AJ Riley TA. Central respiratory control of A5 and A6 pontine noradrenergic neurons. Am J Physiol 264 R1035-R1044 1993.
Guyenet PG Koshiya N Huangfu D Baraban SC Stornetta RL Li YW. Role of medulla oblongata in generation of sympathetic and vagal outfl ows. Prog Brain Res 107127-144 1996.
Hui AS Striet JB Gudelsky G Soukhova GK Gozal E Beitner-Johnson D Guo SZ Sachleben LR Jr Haycock JW Gozal D Czyzyk-Krzeska MF. Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension 42 1130-1136 2003.
Hokfelt T Johansson O Fuxe K Goldstein M Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. I. Tyrosine hydroxylase in the mes- and diencephalon. Med Biol 54 427-453 1976.
Horsburgh A Massoud TF. Th e circumventricular organs of the brain: conspicuity on clinical 3T MRI and a review of functional anatomy. Surg Radiol Anat 35 343-349 2013.
Kvetnansky R Sabban EL Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89 535-606 2009.
Kobayashi K. Role of catecholamine signaling in brain and nervous system functions: new insights from mouse molecular genetic study. J Investig Dermatol Symp Proc 6 115-121 2001.
Lee CR Tepper JM. Basal ganglia control of substantia nigra dopaminergic neurons. J Neural Transm Suppl 73 71-90 2009.
Lindvall O Bjorklund A. Dopamine- and Norepinephrine-Containing Neuron Systems: Th eir Anatomy in the Rat Brain. In: Emson PC (Ed) Chemical Neuroanatomy Raven Press New York 229-256 1983.
Linner L Wiker C Wadenberg ML Schalling M Svensson TH. Noradrenaline reuptake inhibition enhances the antipsychotic-like eff ect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat. Neuropsychopharmacology 27 691-698 2002.
MacInnes JJ Dickerson KC Chen N Adcock RA. Cognitive neurostimulation: learning to volitionally sustain ventral tegmental area activation. Neuron 89 1331-1342 2016.
Majercikova Z van Weering H Scsukova S Mikkelsen JD Kiss A. A new approach of light microscopic immunohistochemical triple-staining: combination of Fos labeling with diaminobenzidine-nickel and neuropeptides labeled with Alexa488 and Alexa555 fl uorescent dyes. Endocr Regul 46 217-223 2012.
Majercikova Z Cernackova A Horvathova L Osacka J Pecenak J Kiss A. Eff ect of acute asenapine treatment on Fos expression in frontal brain structures under normal conditions and mild stress preconditioning in rat. Brain Res Bull 108 60-66 2014.
Majercikova Z Kiss A. Stress alters asenapine-induced Fos expression in the Meynert’s nucleus: response of adjacent hypocretin and melanin-concentrating hormone neurons in rat. Neurol Res 38 32-39 2016.
Morgan JI Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible protooncogenes fos and jun. Annu Rev Neurosci 14 421-451 1991.
Moriizumi T Leduc-Cross B Wu JY Hattori T. Separate neuronal populations of the rat substantia nigra pars lateralis with distinct projection sites and transmitter phenotypes. Neuroscience 46 711-720 1992.
Nikulina EM Covington HE 3rd Ganschow L Hammer RP Jr Miczek KA. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala. Neuroscience 123 857-865 2004.
Nilsson LK Schwieler L Engberg G Linderholm KR Erhardt S. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms. Int J Neuropsychopharmacol 8 329-339 2005.
Ohashi K Hamamura T Lee Y Fujiwara Y Suzuki H Kuroda S. Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by β-adrenoceptors. Neuropsychopharmacology 23 162-169 2000.
Ossenkopp KP Eckel LA. Toxin-induced conditioned changes in taste reactivity and the role of the chemosensitive area postrema. Neurosci Biobehav Rev 19 99-108 1995.
Pacak K Palkovits M. Stressor specifi city of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 22 502-548 2001.
Paxinos G Watson C. Th e Rat Brain in Stereotaxic coordinates compact 6th ed. Academic Press Sydney 2007.
Ranaldi R. Dopamine and reward seeking: the role of ventral tegmental area. Rev Neurosci 25 621-630 2014.
Samuels ER Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Cur Neuropharmacol 6 254-285 2008.
Santos CA Andersen ML Lima MMS Tufi k S. Gentle handling temporarily increases c-Fos in the substantia nigra pars compacta. Braz J Med Biol Res 41 920-925 2008.
Swanson LW Hartman BK. Th e central adrenergic system. An immunofl uorescence study of the location of cell bodies and their eff erent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163 467-505 1975.
Thor KB Helke CJ. Catecholamine-synthesizing neuronal projections to the nucleus tractus solitarii of the rat. J Comp Neurol 268 264-280 1988.
Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiologica 82 1-48 1971.
Westerink BH Kawahara Y De Boer P Geels C De Vries JB Wikstrom HV Van Kalkeren A Van Vliet B Kruse CG Long SK. Antipsychotic drugs classifi ed by their eff ects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur J Pharmacol 412 127-138 2001.
Westlund KN Coulter JD. Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry. Brain Res 2 235-264 1980.
Williams CL Men D Clayton EC. Th e eff ects of noradrenergic activation of the nucleus tractus solitarius on memory and in potentiating norepinephrine release in the amygdala. Behav Neurosci 114 1131-1144 2000.
Wirtshafter D Asin K. Dopamine antagonists induce Fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat. Brain Res 670 205-214 1995.
Woodruff ML Baisden RH Whittington DL Kelly JE. Inputs to the pontine A5 noradrenergic cell group: a horseradish peroxidase study. Exp Neurol 94 782-787 1986.
Yun IA Wakabayashi KT Fields HL Nicola SM. Th e ventral tegmental area is required for the behavioral and nucleus accumbens neuronal fi ring responses to incentive cues. J Neurosci 4 2923-2933 2004.